ASHISH JAIN; ABHISHEK SENGUPTA; PRIYANKA NARAD. CONSTITUTIVELY ACTIVATED TYROSINE KINASE INHIBITOR DRUG DESIGN: HOMOLOGY MODELING AND DOCKING STUDIES ON CHRONIC MYELOGENOUS LEUKEMIA BCR-ABL FUSION PROTEIN. International Journal of Pharma and Bio Sciences, [S. l.], v. 6, n. 2, p. 1215–1225, 2015. Disponível em: https://ijpbs.net/index.php/journal/article/view/4340. Acesso em: 24 jul. 2026.